Blood basophils among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) may indicate the degree of inflammation, according to findings published in the European Archives of ...

Speaker Mike Johnson (R-La.) on Thursday signaled that changes will be made to the party’s mega-bill full of President Trump’s legislative priorities in order to win support from conservative ...

Tezepelumab (Tezspire) has shown significant clinical benefits in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), including marked reductions in nasal congestion and polyp ...

A combination of timely interventions now and proactive protocols next winter can benefit patients who experience exacerbated symptoms at certain times of the year.

May 14, 2025 — A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by ...

Two British academics discovered that a “copy” of the medieval text, held in Harvard Law School’s library for 80 years, is one of seven originals dating from 1300. By Stephen Castle ...

Director of National Intelligence Tulsi Gabbard accused former FBI Director James Comey of “issuing a hit” on President Trump late Thursday, arguing he should be “put behind bars” after ...

And the recalcitrant public statements by Mr. Trump and members of his cabinet have raised questions about whether his administration is openly defying the Supreme Court’s instructions — and ...

It is currently approved for certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, CSU, and chronic obstructive ...

Estimates vary, but some suggest roughly 8 percent of plants worldwide have “recalcitrant” seeds that retain water. Many are concentrated in tropical areas. When the seeds are frozen ...

Chronic inflammation refers to a prolonged inflammatory response that involves a progressive change in the type of cells present at the site of inflammation. It is characterized by the ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...